141 related articles for article (PubMed ID: 133755)
1. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Gibson SL; Hilf R
Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
[TBL] [Abstract][Full Text] [Related]
2. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
[TBL] [Abstract][Full Text] [Related]
3. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
4. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Shafie SM; Hilf R
Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
[TBL] [Abstract][Full Text] [Related]
5. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
6. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Gibson SL; Hilf R
Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
[TBL] [Abstract][Full Text] [Related]
7. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
Bradley CJ; Kledzik GS; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
[TBL] [Abstract][Full Text] [Related]
9. Effects of estrogen to alter amino acid transport in R3230AC mammary carcinomas and its relationship to insulin action.
Hissin PJ; Hilf R
Cancer Res; 1979 Sep; 39(9):3381-7. PubMed ID: 157804
[TBL] [Abstract][Full Text] [Related]
10. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
DeSombre ER; Kledzik G; Marshall S; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
13. Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
Boylan ES; Wittliff JL
Cancer Res; 1975 Mar; 35(3):506-11. PubMed ID: 163681
[TBL] [Abstract][Full Text] [Related]
14. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
[TBL] [Abstract][Full Text] [Related]
15. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Sylvester PW; Ip C; Ip MM
Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
[TBL] [Abstract][Full Text] [Related]
16. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
[TBL] [Abstract][Full Text] [Related]
17. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
[TBL] [Abstract][Full Text] [Related]
18. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
19. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
20. Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat.
Ip C; Ip MM
J Natl Cancer Inst; 1981 Feb; 66(2):291-5. PubMed ID: 6779045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]